Year: 2013
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: To investigate MRI and proton magnetic resonance spectroscopy (MRS) predictors of mild cognitive impairment (MCI) in cognitively normal older adults. METHODS: Subjects were cognitively normal older adults (n = 1,156) who participated in the population-based Mayo Clinic Study of Aging MRI/MRS study from August 2005 to December 2010 and had at least one annual clinical follow-up. Single-voxel MRS was performed from the posterior cingulate gyri, and hippocampal volumes and white matter hyperintensity volumes were quantified using automated methods. Brain infarcts were assessed on MRI. Cox proportional hazards regression, with age as the time scale, was used to assess the effect of MRI and MRS markers on the risk of progression from cognitively normal to MCI. Linear mixed-effects models were used to assess the effect of MRI and MRS markers on cognitive decline. RESULTS: After a median follow-up of 2.8 years, 214 participants had progressed to MCI or dementia (estimated incidence rate = 6.1% per year; 95% confidence interval = 5.3%-7.0%). In univariable modeling, hippocampal volume, white matter hyperintensity volume, and N-acetylaspartate/myo-inositol were significant predictors of MCI in cognitively normal older adults. In multivariable modeling, only decreased hippocampal volume and N-acetylaspartate/myo-inositol were independent predictors of MCI. These MRI/MRS predictors of MCI as well as infarcts were associated with cognitive decline (p < 0.05). CONCLUSION: Quantitative MRI and MRS markers predict progression to MCI and cognitive decline in cognitively normal older adults. MRS may contribute to the assessment of preclinical dementia pathologies by capturing neurodegenerative changes that are not detected by hippocampal volumetry.
Source: Neurology
Authors: Kejal Kantarci, Stephen D. Weigand, Scott A. Przybelski, Gregory M. Preboske, V. Shane Pankratz, Prashanthi Vemuri, Matthew L. Senjem, Matthew C. Murphy, Jeffrey L. Gunter, Mary M. Machulda, Robert J. Ivnik, Rosebud O. Roberts, Bradley F. Boeve, Walter A. Rocca, David S. Knopman, Ronald C. Petersen, Clifford R. Jack
Institution: Mayo Clinic
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Health and Human Services, Alzheimer's Association, Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, American Academy of Neurology, Mayo Foundation for Medical Education and Research, Walter S. and Lucienne Driskill Foundation, National Institutes of Health, National Institute on Aging, National Center for Research Resources, Janssen Pharmaceuticals
Awards: Sex-specific Risk for Vascular Dysfunction and Cognitive Decline, Pathological basis of MRS and DTI changes in neurodegenerative dementia, Alzheimers Disease Patient Registry, Evaluating and Extending Our Hypothetical Model of Alzheimer's Biomarkers, G6206414941, EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM, Brain Aging and Alzheimer's Biomarker Classification Using Amyloid PET, tau PET, and Neurodegeneration on MRI: Developing the ATN system, G9000038603
OpenAlex ID: W2008762660
